The Collaboration for Health in Papua New Guinea (CHPNG) is a partnership aiming at building the local capacity of the health workers and the local communities of PNG to HIV. This document provides an acquittal for two years of work by NAPWHA under a contract dated October 2016.
This paper explores the role of People with HIV (PLHIV) in the HIV prevention response in Australia since the beginning of the epidemic.
NAPWHA Treatment Factsheet 1: Are you on the best HIV treatment? There are so many different HIV treatments available today that everybody is now able to find a combination that is best for them.
NAPWHA Treatment Factsheet 2: Can you avoid HIV drug resistance? There is not one type of HIV about but rather a large population of mixed viruses, some of which are drug-resistant.
NAPWHA Treatment Factsheet 3: Are you heading for a treatment clash? Combined with HIV treatment, some drug combinations can cause serious side-effects and make one or both drugs ineffective or toxic.
NAPWHA Treatment Factsheet 4: How confident are you that HIV treatment is prevention? We always knew that treatment reduced the chance of passing on HIV, but proving that it eliminated the risk took some time.
NAPWHA Treatment Factsheet 5: What does HIV Pre-Exposure Prophylaxis (PrEP) mean for people with HIV? PrEP is having a more profound and personal impact on our lives than we imagine.
The life expectancy of Australians living with HIV has been steadily increasing and is approaching that of the general population. For them, and for the community organisations that serve and represent them, living simultaneously
with HIV and with the consequences of ageing is a ‘new frontier’. This report describes and synthesises the work that has been carried out by NAPWHA to address this challenge now and into the future.